EWA
VERA icon

EverSource Wealth Advisors’s Vera Therapeutics VERA Stock Holding History

EverSource Wealth Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$944 Buy
22
+17
+340% +$633 ﹤0.01% 3984
2026
Q1 		$201 Buy
5
+4
+400% +$172 ﹤0.01% 4198
2025
Q4 		$51 Buy
+1
New +$36 ﹤0.01% 4170
2025
Q3 		– Sell
-6
Closed -$141 – 4487
2025
Q2 		$141 Buy
+6
New +$135 ﹤0.01% 4091

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

EverSource Wealth Advisors's VERA Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Vera Therapeutics (VERA) stake by 340% in Q2 2026, buying an estimated $633 and bringing the position to 22 shares worth $944. The position accounts for ﹤0.01% of the portfolio, ranked #3984.

EverSource Wealth Advisors first reported a position in VERA in Q2 2025 and has held it in 4 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • EverSource Wealth Advisors held 22 shares of Vera Therapeutics worth $944 as of Q2 2026.
  • EverSource Wealth Advisors bought 17 Vera Therapeutics shares in Q2 2026, an estimated $633.
  • Vera Therapeutics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3984 holding.
  • EverSource Wealth Advisors first reported a position in Vera Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.